Form 4: Hims & Hers Health Chief Legal Officer Soleil Boughton Reports Stock Sale

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., reported the sale of 4,153 shares of Class A Common Stock on February 3, 2025, at a price of $35.3 per share.

Summary

• On February 3, 2025, Soleil Boughton, the Chief Legal Officer of Hims & Hers Health, Inc., sold 4,153 shares of Class A Common Stock.
• The sale was executed at a price of $35.3 per share.
• Following the transaction, Boughton directly owns 161,497 shares of Class A Common Stock.
• The sale was conducted under a Rule 10b5-1 trading plan adopted on August 28, 2024.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing reporting a stock sale by an officer. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders. The use of a 10b5-1 trading plan suggests the insider planned the transaction in advance.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders, potentially creating slight downward pressure on the stock price in the short term.

Key Dates

Keywords

Form 4, Hims & Hers Health, Stock Sale, Soleil Boughton, Chief Legal Officer, Rule 10b5-1, Insider Trading